Derivative exercise or conversion — not an open-market buy.
Loading…
Traded Feb 19, 2026 · Filed Feb 20, 2026
A board member of F5, Inc. sold $487K of F5, Inc. shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$487,193
Shares × reported transaction price
23 days after results of Jan 27, 2026, 68 days before results of Apr 28, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $279.19 on Feb 19, 2026, 25% above its 52-week low and 19% below its high, after a 3% rise over the previous 30 trading days
52-week range $223.99 (Nov 19, 2025) to $343.17 (Oct 14, 2025), 46% of the way up, from 251 adjusted closes. 30 trading days earlier: $270.64 on Jan 6, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.1% | +0.6% | +2.6% |
| 30 days | +10.5% | -3.8% | +14.3% |
| 90 days | +47.3% | +10.0% | +37.3% |
| 180 days | +40.6% | +11.9% | +28.8% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Compensation award — excluded from discretionary-purchase analysis.
Derivative exercise or conversion — not an open-market buy.
